These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1732342)

  • 1. Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. The German Multicenter Study.
    Christophers E; Mrowietz U; Henneicke HH; Färber L; Welzel D
    J Am Acad Dermatol; 1992 Jan; 26(1):86-90. PubMed ID: 1732342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose cyclosporine A improves severe disabling psoriasis in Latin America. Latin American Multicenter Study.
    Honeyman JF; Sánchez L; Valdés P
    Int J Dermatol; 1995 Aug; 34(8):583-8. PubMed ID: 7591445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
    Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
    Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.
    Faerber L; Braeutigam M; Weidinger G; Mrowietz U; Christophers E; Schulze HJ; Mahrle G; Meffert H; Drechsler S
    Am J Clin Dermatol; 2001; 2(1):41-7. PubMed ID: 11702620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study. German Multicenter Study.
    Mrowietz U; Färber L; Henneicke-von Zepelin HH; Bachmann H; Welzel D; Christophers E
    J Am Acad Dermatol; 1995 Sep; 33(3):470-5. PubMed ID: 7657870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine as maintenance therapy in patients with severe psoriasis.
    Shupack J; Abel E; Bauer E; Brown M; Drake L; Freinkel R; Guzzo C; Koo J; Levine N; Lowe N; McDonald C; Margolis D; Stiller M; Wintroub B; Bainbridge C; Evans S; Hilss S; Mietlowski W; Winslow C; Birnbaum JE
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):423-32. PubMed ID: 9091474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis.
    Yoon HS; Youn JI
    J Dermatolog Treat; 2007; 18(5):286-90. PubMed ID: 17852632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study.
    Grossman RM; Thivolet J; Claudy A; Souteyrand P; Guilhou JJ; Thomas P; Amblard P; Belaich S; de Belilovsky C; de la Brassinne M
    J Am Acad Dermatol; 1994 Jul; 31(1):68-74. PubMed ID: 8021375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term considerations concerning the management of plaque psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO).
    Dermatology; 1993; 187 Suppl 1():19-29. PubMed ID: 8369576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclosporine and psoriasis: experience with 14 patients].
    Gajardo J
    Rev Med Chil; 1993 Dec; 121(12):1411-5. PubMed ID: 8085065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure.
    Lowe NJ; Wieder JM; Rosenbach A; Johnson K; Kunkel R; Bainbridge C; Bourget T; Dimov I; Simpson K; Glass E; Grabie MT
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):710-9. PubMed ID: 8912566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine therapy for psoriasis: a cell cycle-derived dosing schedule.
    Goodman MM; White GM; McCormick A; McCullough J; Weinstein G
    J Am Acad Dermatol; 1992 Oct; 27(4):594-8. PubMed ID: 1401311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
    Zachariae H; Abrams B; Bleehen SS; Bräutigam M; Burrows D; Ettelt MJ; Fry L; Happle R; Haustein UF; Ganslandt J; Jung EG; Knop J; Kühne KH; Mellein B; Mørk NJ; Rogers S; Schmidt AG; Schopf RE; Sumner M; Taube KM; Weidinger G; Wurdel C; Zahn E
    Dermatology; 1998; 196(2):231-6. PubMed ID: 9568413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
    Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
    J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial.
    Ellis CN; Fradin MS; Messana JM; Brown MD; Siegel MT; Hartley AH; Rocher LL; Wheeler S; Hamilton TA; Parish TG
    N Engl J Med; 1991 Jan; 324(5):277-84. PubMed ID: 1986287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study.
    Colombo D; Cassano N; Altomare G; Giannetti A; Vena GA
    Int J Immunopathol Pharmacol; 2010; 23(4):1143-52. PubMed ID: 21244763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group.
    Ho VC; Griffiths CE; Albrecht G; Vanaclocha F; León-Dorantes G; Atakan N; Reitamo S; Ohannesson A; Mørk NJ; Clarke P; Pfister P; Paul C
    Br J Dermatol; 1999 Aug; 141(2):283-91. PubMed ID: 10468801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile.
    Meffert H; Bräutigam M; Färber L; Weidinger G
    Acta Derm Venereol; 1997 Mar; 77(2):137-41. PubMed ID: 9111826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy.
    Ellis CN; Fradin MS; Hamilton TA; Voorhees JJ
    Arch Dermatol; 1995 Jul; 131(7):791-5. PubMed ID: 7611794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.